Natraj Proteins Ltd
₹34.81
(-5.66%)
Mon, 06 Apr 2026, 06:52 pm
Natraj Proteins Ratios
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 7.06 | 4.04 | 1.34 | 4.91 | 3.39 | 1.67 | 0.95 | 1.39 | 10.38 | 0 | 52.54 | 6.84 | 8.79 | 24.44 | 26.38 | 4.21 | 20.31 | 0 | 0 |
| Price to book ratio | 0.40 | 0.53 | 0.33 | 0.55 | 0.37 | 0.31 | 0.35 | 0.30 | 0.42 | 0.30 | 0.37 | 0.32 | 0.28 | 0.23 | 0.29 | 0.87 | 0.31 | 0.43 | 0.43 |
| Price to sales ratio | 0.03 | 0.04 | 0.02 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 | 0.07 | 0.27 | 0.10 | 0.08 | 0.12 |
| Price to cash flow ratio | 0 | 0 | 0.74 | 0.50 | 0 | 0 | 0.38 | 0 | 0.76 | 1.71 | 0 | 0 | 0.39 | 0 | 1.53 | 7.74 | 12.78 | 0 | 0.72 |
| Enterprise value | 170.28M | 231.54M | 194.62M | 149.65M | 369.69M | 554.63M | 353.09M | 523.61M | 387.08M | 230.32M | 273.96M | 647.9M | 368.33M | 367.96M | 323.13M | 612.18M | 453.42M | 534.26M | 361.41M |
| Enterprise value to EBITDA ratio | 7.55 | 6.73 | 2.97 | 4.82 | 7.86 | 5.95 | 1.75 | 3.44 | 6.50 | 0 | 6.89 | 10.25 | 6.14 | 8.14 | 10.47 | 4.32 | 14.38 | 0 | 30.25 |
| Debt to equity ratio | 1.82 | 1.81 | 1.54 | 0.83 | 2.24 | 2.66 | 1.39 | 1.34 | 1.13 | 0.60 | 0.58 | 1.58 | 0.87 | 0.87 | 0.61 | 0.60 | 0.73 | 1.19 | 0.70 |
| Return on equity % | 0 | 13.82 | 26.06 | 10.97 | 11.49 | 20.69 | 44.64 | 23.99 | 4.01 | -15.09 | 0.70 | 4.79 | 3.29 | 0.95 | 1.10 | 22.97 | 1.55 | -31.32 | -4.44 |
Natraj Proteins Ltd Ratios
The Natraj Proteins Ltd Ratios page provides a complete fundamental analysis of Natraj Proteins Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Natraj Proteins Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Natraj Proteins Ltd (NSE: , BSE: 530119) is currently trading at ₹34.81, with a market capitalization of ₹130.43M. As a major player in the Process industries sector and Agricultural commodities/Milling industry, Natraj Proteins Ltd remains a key stock for fundamental analysis using Natraj Proteins Ltd Ratios.
Natraj Proteins Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Natraj Proteins Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Natraj Proteins Ltd Ratios.
Historically, the Natraj Proteins Ltd P/E ratio has shown strong fluctuations:
- 2024: 0
- 2023: 0
- 2022: 20.31
- 2021: 4.21
- 2020: 26.38
The decline in Natraj Proteins Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Natraj Proteins Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.43.
Historical P/B trend:
- 2024: 0.43
- 2023: 0.43
- 2022: 0.31
- 2021: 0.87
Natraj Proteins Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Natraj Proteins Ltd P/S ratio currently stands at 0.12, an important part of Natraj Proteins Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.12
- 2023: 0.08
- 2022: 0.10
- 2021: 0.27
The rising Natraj Proteins Ltd P/S ratio indicates improved revenue valuation by investors.
Natraj Proteins Ltd Price to Cash Flow Ratio (P/CF)
The Natraj Proteins Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.72.
Historical Natraj Proteins Ltd Price to Cash Flow Ratio:
- 2024: 0.72
- 2023: 0
- 2022: 12.78
- 2021: 7.74
- 2020: 1.53
The rising Natraj Proteins Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Natraj Proteins Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Natraj Proteins Ltd EV currently stands at ₹361.41M, representing the total company valuation including debt.
Historical EV trend:
- 2024: 361.41M
- 2023: 534.26M
- 2022: 453.42M
- 2021: 612.18M
Natraj Proteins Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Natraj Proteins Ltd EV/EBITDA ratio is currently 30.25, a key metric in Natraj Proteins Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 30.25
- 2023: 0
- 2022: 14.38
- 2021: 4.32
Higher Natraj Proteins Ltd EV/EBITDA suggests premium valuation.
Natraj Proteins Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Natraj Proteins Ltd D/E ratio is currently 0.70, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.70
- 2023: 1.19
- 2022: 0.73
- 2021: 0.60
Natraj Proteins Ltd maintains moderate leverage with manageable risk.
Return on Equity (ROE %)
The Natraj Proteins Ltd ROE currently stands at -4.44%, showing profitability and capital efficiency.
Historical ROE:
- 2024: -4.44
- 2023: -31.32
- 2022: 1.55
- 2021: 22.97
Declining ROE indicates pressure on profitability.
Natraj Proteins Ltd Ratios Analysis Summary
The Natraj Proteins Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Natraj Proteins Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Natraj Proteins Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800